Biogen (BIIB) Construction in Progress (2009 - 2025)
Biogen's Construction in Progress was $163.1 million in Q4 2025, down 47.1% from $308.4 million a year earlier.
Powered by 
Analysis
Biogen (BIIB) Construction in Progress (2009 - 2025) Analysis & Trends
From Q4 2009 onward, Biogen has reported Construction in Progress for 46 quarters.
- Construction in Progress shows a five-year compound annual growth rate of -39.1% (FY2020 to FY2025).
- In earlier years, Construction in Progress was $308.4 million in FY2024 (-68.4%), $975.4 million in FY2023 (+9.7%), $888.8 million in FY2022 (+15.4%) and $770.3 million in FY2021 (-60.5%).
- The Q4 2025 figure marks the lowest quarterly Construction in Progress since Q1 2016.
- The best year-over-year quarter for Construction in Progress over five years was Q4 2022 (growth of 15.4%); the worst was Q4 2024 (a decline of 68.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 163.10 Mn |
| Dec 31, 2024 | 308.40 Mn |
| Dec 31, 2023 | 975.40 Mn |
| Sep 30, 2023 | 742.00 Mn |
| Jun 30, 2023 | 732.20 Mn |
| Mar 31, 2023 | 721.20 Mn |
| Dec 31, 2022 | 888.80 Mn |
| Sep 30, 2022 | 701.00 Mn |
| Jun 30, 2022 | 691.70 Mn |
| Mar 31, 2022 | 682.60 Mn |
| Dec 31, 2021 | 770.30 Mn |
| Sep 30, 2021 | 661.80 Mn |
| Jun 30, 2021 | 618.40 Mn |
| Mar 31, 2021 | 1.90 Bn |
| Dec 31, 2020 | 1.95 Bn |
| Sep 30, 2020 | 1.80 Bn |
| Jun 30, 2020 | 1.70 Bn |
| Mar 31, 2020 | 1.70 Bn |
| Dec 31, 2019 | 2.08 Bn |
| Sep 30, 2019 | 1.80 Bn |
API Access
Biogen Construction in Progress API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=construction-in-progress&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "construction-in-progress", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=construction-in-progress&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();